Authors: RASSMANN I THODTMANN R DEPENBROCK H BLATTER J GATZEMEIER U RASTETTER J HANAUSKE AR

Citation: I. Rassmann et al., GEMCITABINE AND ETOPOSIDE IN SMALL-CELL LUNG-CANCER - PHASE-I AND PHASE-II TRIALS, Seminars in oncology, 24(2), 1997, pp. 75-78

Authors: RASSMANN I SCHRODEL H SCHILLING T ZUCCHETTI M KAESERFROHLICH A RASTETTER J HANAUSKE AR

Citation: I. Rassmann et al., CLINICAL AND PHARMACOKINETIC PHASE-I TRIAL OF ORAL DIMETHYLAMINOETOPOSIDE (NK611) ADMINISTERED FOR 21 DAYS EVERY 35 DAYS, Investigational new drugs, 14(4), 1996, pp. 379-386

Authors: RASSMANN I SCHILLING T SCHRODEL H KAESERFROHLICH A BURK K RASTETTER J HANAUSKE AR

Citation: I. Rassmann et al., PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF THE PODOPHYLLOTOXIN DERIVATIVE NK-611 USING AN ORAL DAILY ADMINISTRATION SCHEDULE, European journal of cancer, 31A, 1995, pp. 111-111